Deborah Schrag

Deborah Schrag has led pivotal evaluations of multi-cancer early detection test clinical utility, designing rigorous comparative effectiveness studies that assess not only diagnostic accuracy but also downstream health outcomes and healthcare utilization. Her work on cancer care delivery research has informed the practical implementation challenges of MCED testing in diverse healthcare settings. Her expertise in screening trial methodology has shaped the evidentiary framework for regulatory approval of blood-based cancer screening tests.